[1] VAKIL N, VAN ZANTEN SV, KAHRILAS P, et al. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol,2006, 101(8): 1900–1920.
[2] El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastrooesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6):871–880.
[3] Fock K M, Talley N, Goh K L, et al. Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus[J]. Gut, 2016, 65(9):1402.
[4] Chen Yuhu, Hou Xiaohua, Xiao Yinglian, et al. Consensus opinion of Chinese patients with gastroesophageal reflux disease in 2014[J]. Chin J Gastroenterol, 2015, 20(03):155–168.
[5] Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study[J]. Alimentary Pharmacology & Therapeutics, 2003, 17(12):1515–1520.
[6] Ford AC, Suares NC, Talley NJ. Meta-analysis: the epidemiology of noncardiac chest pain in the community. Aliment Pharmacol Ther. 2011 Jul;34(2):172–80.
[7] Fass R,Di ckman R. Non- cardiac chest pain: an update[J]. Neurogastroenterol Motil. 2006 Jun;18(6):408–17.
[8] Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE; International High Resolution Manometry Working Group. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015 Feb;27(2):160–74.
[9] Zhao Yingpan, Liao Yu, Zhong Jiayu, et al. Comparative study of Gastroesophageal Reflux Disease Questionnaire and Reflux Disease Questionnaire[J]. Chin J Gastroenterol Hepatol, 2015, 24 (5): 572–574.
[10] Li Jun, Feng Yi, Han Jisheng, et al. Multi-centered linguistic adaptation and validation of short-form McGill Pain Questionnaire–2[J]. Chinese Journal of Pain Medicine, 2013, 19(1): 42–46.
[11] Zhu Qing, Yan Xiaohong, Huang Zhongfa, et al. Application SF–36 scale to evaluate the quality of life in gastroesophageal reflux disease[J]. Chin J Diffic and Compl Cas, 2010, 9(3): 188–190.
[12] Belafsy PC, Postma GN, Koufman JA. Vaildity and reliability of the reflux symptom index(RSI)[J]. Journal of Voice 2002, 16(2):274–277.
[13] Dore M P, Pedroni A, Pes G M, et al. Effect of Antisecretory Therapy on Atypical Symptoms in Gastroesophageal Reflux Disease[J]. Digestive Diseases and Sciences, 2007, 52(2):463–468.
[14] Boeckxstaens G E, Beaumont H, Mertens V, et al. Effects of Lesogaberan on Reflux and Lower Esophageal Sphincter Function in Patients With Gastroesophageal Reflux Disease[J]. Gastroenterology, 2010, 139(2):409–417.
[15] Zung W W. A rating instrument for anxiety disorders[J]. Psychosomatics, 1900, 12(6):371–379.
[16] Zung WW. A self-rating depression scale[J]. Arch Gen Psychiatry, 1965, 12:63–70.
[17] Zhou WC, Jia L, Chen DY, Liu Y, Liu J, Jiang SM, Yang M, Xu J. The effects of paroxetine and amitriptyline on the upper esophageal sphincter (UES) pressure and its natural history in globus pharyngeus. Dig Liver Dis. 2017Jul;49(7):757–63.
[18] DeMeester TR, O’Sullivan GC,Bermudez G, Midell AI, Cimochowski GE, O’Drobinak J. Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg 1982; 196: 488–98.
[19] Nasr I, Attaluri A, Coss-Adame E, Rao SS. Diagnostic utility of the oesophageal balloon distension test in the evaluation of oesophageal chest pain. Aliment Pharmacol Ther 2012; 35: 1474–81.
[20] Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115: 42–9.
[21] Castell DO, Murray JA, Tutuian R, Orlando RC, Arnold R. Review article: the pathophysiology of gastrooesophageal reflux disease—oesophageal manifestations. Aliment Pharmacol Ther. 2004;20(Suppl 9):14–25.
[22] de Bortoli N, Ottonello A, Zerbib F, Sifrim D, Gyawali CP, Savarino E. Between GERD and NERD: the relevance of weakly acidic reflux. Ann N Y Acad Sci. 2016;1380(1):218–29.
[23] Dodds WJ, Dent J, Hogan WJ, et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N Engl J Med 1982;307:1547–1552.
[24] Dent J, Dodds WJ, Friedman RH, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980;65:256–267.
[25] Bredenoord AJ, Weusten BL, Timmer R, Smout AJ. Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux. Gastroenterology. 2006;130(2):334–40.
[26] Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, Vaezi M, Sifrim D, Fox MR, Vela MF, Tutuian R, Tack J, Bredenoord AJ, Pandolfino J, Roman S. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018 Jul;67(7):1351–1362.
[27] Rey E, Barceló M, Zapardiel J, et al. Is the reflux disease questionnaire useful for identifying GERD according to the Montreal definition?[J]. BMC Gastroenterology, 2014, 14(1):1–11.
[28] Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Furuta K, Kinoshita Y: Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005;40:1005–1009.
[29] SMOUT, A. J. P.M., Endoscopy-negative acid reflux disease. Alimentary Pharmacology & Therapeutics, 1997. 11(s2): p. 81–85.
[30] Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology. 1986 Oct;91(4):845–52.
[31] Sarkar S, Aziz Q, Woolf CJ, Hobson AR, Thompson DG. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet. 2000 Sep 30;356(9236):1154–9.
[32] Shelby R A, Somers T J, Keefe F J, et al. Pain catastrophizing in patients with noncardiac chest pain: relationships with pain, anxiety, and disability[J]. Psychosomatic Medicine, 2009, 71(8):861–868.
[33] Yang X J, Jiang H M, Hou X H, et al. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life[J]. World Journal of Gastroenterology, 2015, 21(14):4302–4309.
[34] Kovács Z, Kerékgyártó O. Psychological factors, quality of life, and gastrointestinal symptoms in patients with erosive and non-erosive reflux disorder. Int J Psychiatry Med. 2007;37(2):139–50.
[35] Rabiee B, Motamed N, Hosseini V, et al. Gastroesophageal reflux disease (GERD) prevalence and related risk factors in north of Iran[J]. Esophagus, 2016, 13(4):330–336.
[36] Naik RD, Evers L, Vaezi MF. Advances in the Diagnosis and Treatment of GERD: New Tricks for an Old Disease. Curr Treat Options Gastroenterol. 2019 Mar;17(1):1–17.